Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
High-dose imatinib induction followed by standard-dose maintenance in pre-treated chronic phase chronic myeloid leukemia patients--final analysis of a randomized, multicenter, phase III trial.
Haematologica. 2012 Oct;97(10):1562-9. doi: 10.3324/haematol.2011.060087. Epub 2012 Apr 17.
Haematologica. 2012.
PMID: 22511495
Free PMC article.
Clinical Trial.
High-dose imatinib improves cytogenetic and molecular remissions in patients with pretreated Philadelphia-positive, BCR-ABL-positive chronic phase chronic myeloid leukemia: first results from the randomized CELSG phase III CML 11 "ISTAHIT" study.
Petzer AL, Wolf D, Fong D, Lion T, Dyagil I, Masliak Z, Bogdanovic A, Griskevicius L, Lejniece S, Goranov S, Gercheva L, Stojanovic A, Peytchev D, Tzvetkov N, Griniute R, Oucheva R, Ulmer H, Kwakkelstein M, Rancati F, Gastl G.
Petzer AL, et al. Among authors: kwakkelstein m.
Haematologica. 2010 Jun;95(6):908-13. doi: 10.3324/haematol.2009.013979. Epub 2010 Feb 9.
Haematologica. 2010.
PMID: 20145273
Free PMC article.
Clinical Trial.
Item in Clipboard
The steady-state pharmacokinetics of efavirenz and nevirapine when used in combination in human immunodeficiency virus type 1-infected persons.
Veldkamp AI, Harris M, Montaner JS, Moyle G, Gazzard B, Youle M, Johnson M, Kwakkelstein MO, Carlier H, van Leeuwen R, Beijnen JH, Lange JM, Reiss P, Hoetelmans RM.
Veldkamp AI, et al. Among authors: kwakkelstein mo.
J Infect Dis. 2001 Jul 1;184(1):37-42. doi: 10.1086/320998. Epub 2001 May 30.
J Infect Dis. 2001.
PMID: 11398107
Clinical Trial.
Item in Clipboard
Nevirapine plus didanosine: once or twice daily combination?
van Heeswijk RP, Veldkamp AI, Mulder JW, Meenhorst PL, Wit FW, Reiss P, Lange JM, Kwakkelstein MO, Beijnen JH, Hoetelmans RM.
van Heeswijk RP, et al. Among authors: kwakkelstein mo.
J Acquir Immune Defic Syndr. 2000 Sep 1;25(1):93-5. doi: 10.1097/00042560-200009010-00014.
J Acquir Immune Defic Syndr. 2000.
PMID: 11064511
No abstract available.
Item in Clipboard
Safety and biodistribution of 99mTechnetium-labeled anti-CD44v6 monoclonal antibody BIWA 1 in head and neck cancer patients.
Stroomer JW, Roos JC, Sproll M, Quak JJ, Heider KH, Wilhelm BJ, Castelijns JA, Meyer R, Kwakkelstein MO, Snow GB, Adolf GR, van Dongen GA.
Stroomer JW, et al. Among authors: kwakkelstein mo.
Clin Cancer Res. 2000 Aug;6(8):3046-55.
Clin Cancer Res. 2000.
PMID: 10955783
Clinical Trial.
Item in Clipboard
The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals.
van Heeswijk RP, Veldkamp AI, Mulder JW, Meenhorst PL, Wit FW, Lange JM, Danner SA, Foudraine NA, Kwakkelstein MO, Reiss P, Beijnen JH, Hoetelmans RM.
van Heeswijk RP, et al. Among authors: kwakkelstein mo.
AIDS. 2000 May 26;14(8):F77-82. doi: 10.1097/00002030-200005260-00001.
AIDS. 2000.
PMID: 10853971
Clinical Trial.
Item in Clipboard
Cite
Cite